The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Anti-parasitic drugs mainly include: anti-malaria drugs, anti-amebiasis drugs and anti-trichomoniasis drugs, anti-leishmaniasis drugs, anti-fluke drugs and anti-filariasis drugs, intestinal anthelmintics, other parasitic drugs and other drugs.
The global Ectoparasiticides market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Ectoparasiticides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ectoparasiticides.
Report Scope
The Ectoparasiticides market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ectoparasiticides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ectoparasiticides companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Bayer
- MSD Animal Health
- Boehringer Ingelheim
- Ceva Sante Animale
- Eli Lilly and Company
- Zoetis
- Sanofi
- Virbac
- Vetoquinol
- Dechra Pharmaceuticals
- Advance Properties OOD/Huvepharma
- Heranba
- Tagros
- Meghmani
- Crop Life Science Limited
- Aestar
- Gharda
- Guangdong Liwei
Segment by Type
- Permethrin
- Sulfur
- Lindane
- Benzyl Benzoate
- Ivermectin
- Others
Segment by Application
- Dogs
- Cats
- Cattle
- Pigs
- Sheep and Goats
- Poultry
- Others
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ectoparasiticides companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ectoparasiticides Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Permethrin
1.2.3 Sulfur
1.2.4 Lindane
1.2.5 Benzyl Benzoate
1.2.6 Ivermectin
1.2.7 Others
1.3 Market by Application
1.3.1 Global Ectoparasiticides Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Dogs
1.3.3 Cats
1.3.4 Cattle
1.3.5 Pigs
1.3.6 Sheep and Goats
1.3.7 Poultry
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ectoparasiticides Market Perspective (2019-2030)
2.2 Ectoparasiticides Growth Trends by Region
2.2.1 Global Ectoparasiticides Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Ectoparasiticides Historic Market Size by Region (2019-2024)
2.2.3 Ectoparasiticides Forecasted Market Size by Region (2025-2030)
2.3 Ectoparasiticides Market Dynamics
2.3.1 Ectoparasiticides Industry Trends
2.3.2 Ectoparasiticides Market Drivers
2.3.3 Ectoparasiticides Market Challenges
2.3.4 Ectoparasiticides Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ectoparasiticides Players by Revenue
3.1.1 Global Top Ectoparasiticides Players by Revenue (2019-2024)
3.1.2 Global Ectoparasiticides Revenue Market Share by Players (2019-2024)
3.2 Global Ectoparasiticides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Ectoparasiticides Revenue
3.4 Global Ectoparasiticides Market Concentration Ratio
3.4.1 Global Ectoparasiticides Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ectoparasiticides Revenue in 2023
3.5 Ectoparasiticides Key Players Head office and Area Served
3.6 Key Players Ectoparasiticides Product Solution and Service
3.7 Date of Enter into Ectoparasiticides Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Ectoparasiticides Breakdown Data by Type
4.1 Global Ectoparasiticides Historic Market Size by Type (2019-2024)
4.2 Global Ectoparasiticides Forecasted Market Size by Type (2025-2030)
5 Ectoparasiticides Breakdown Data by Application
5.1 Global Ectoparasiticides Historic Market Size by Application (2019-2024)
5.2 Global Ectoparasiticides Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Ectoparasiticides Market Size (2019-2030)
6.2 North America Ectoparasiticides Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Ectoparasiticides Market Size by Country (2019-2024)
6.4 North America Ectoparasiticides Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Ectoparasiticides Market Size (2019-2030)
7.2 Europe Ectoparasiticides Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Ectoparasiticides Market Size by Country (2019-2024)
7.4 Europe Ectoparasiticides Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Ectoparasiticides Market Size (2019-2030)
8.2 Asia-Pacific Ectoparasiticides Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Ectoparasiticides Market Size by Region (2019-2024)
8.4 Asia-Pacific Ectoparasiticides Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Ectoparasiticides Market Size (2019-2030)
9.2 Latin America Ectoparasiticides Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Ectoparasiticides Market Size by Country (2019-2024)
9.4 Latin America Ectoparasiticides Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ectoparasiticides Market Size (2019-2030)
10.2 Middle East & Africa Ectoparasiticides Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Ectoparasiticides Market Size by Country (2019-2024)
10.4 Middle East & Africa Ectoparasiticides Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Ectoparasiticides Introduction
11.1.4 Bayer Revenue in Ectoparasiticides Business (2019-2024)
11.1.5 Bayer Recent Development
11.2 MSD Animal Health
11.2.1 MSD Animal Health Company Detail
11.2.2 MSD Animal Health Business Overview
11.2.3 MSD Animal Health Ectoparasiticides Introduction
11.2.4 MSD Animal Health Revenue in Ectoparasiticides Business (2019-2024)
11.2.5 MSD Animal Health Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Detail
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Ectoparasiticides Introduction
11.3.4 Boehringer Ingelheim Revenue in Ectoparasiticides Business (2019-2024)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Ceva Sante Animale
11.4.1 Ceva Sante Animale Company Detail
11.4.2 Ceva Sante Animale Business Overview
11.4.3 Ceva Sante Animale Ectoparasiticides Introduction
11.4.4 Ceva Sante Animale Revenue in Ectoparasiticides Business (2019-2024)
11.4.5 Ceva Sante Animale Recent Development
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Detail
11.5.2 Eli Lilly and Company Business Overview
11.5.3 Eli Lilly and Company Ectoparasiticides Introduction
11.5.4 Eli Lilly and Company Revenue in Ectoparasiticides Business (2019-2024)
11.5.5 Eli Lilly and Company Recent Development
11.6 Zoetis
11.6.1 Zoetis Company Detail
11.6.2 Zoetis Business Overview
11.6.3 Zoetis Ectoparasiticides Introduction
11.6.4 Zoetis Revenue in Ectoparasiticides Business (2019-2024)
11.6.5 Zoetis Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Detail
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Ectoparasiticides Introduction
11.7.4 Sanofi Revenue in Ectoparasiticides Business (2019-2024)
11.7.5 Sanofi Recent Development
11.8 Virbac
11.8.1 Virbac Company Detail
11.8.2 Virbac Business Overview
11.8.3 Virbac Ectoparasiticides Introduction
11.8.4 Virbac Revenue in Ectoparasiticides Business (2019-2024)
11.8.5 Virbac Recent Development
11.9 Vetoquinol
11.9.1 Vetoquinol Company Detail
11.9.2 Vetoquinol Business Overview
11.9.3 Vetoquinol Ectoparasiticides Introduction
11.9.4 Vetoquinol Revenue in Ectoparasiticides Business (2019-2024)
11.9.5 Vetoquinol Recent Development
11.10 Dechra Pharmaceuticals
11.10.1 Dechra Pharmaceuticals Company Detail
11.10.2 Dechra Pharmaceuticals Business Overview
11.10.3 Dechra Pharmaceuticals Ectoparasiticides Introduction
11.10.4 Dechra Pharmaceuticals Revenue in Ectoparasiticides Business (2019-2024)
11.10.5 Dechra Pharmaceuticals Recent Development
11.11 Advance Properties OOD/Huvepharma
11.11.1 Advance Properties OOD/Huvepharma Company Detail
11.11.2 Advance Properties OOD/Huvepharma Business Overview
11.11.3 Advance Properties OOD/Huvepharma Ectoparasiticides Introduction
11.11.4 Advance Properties OOD/Huvepharma Revenue in Ectoparasiticides Business (2019-2024)
11.11.5 Advance Properties OOD/Huvepharma Recent Development
11.12 Heranba
11.12.1 Heranba Company Detail
11.12.2 Heranba Business Overview
11.12.3 Heranba Ectoparasiticides Introduction
11.12.4 Heranba Revenue in Ectoparasiticides Business (2019-2024)
11.12.5 Heranba Recent Development
11.13 Tagros
11.13.1 Tagros Company Detail
11.13.2 Tagros Business Overview
11.13.3 Tagros Ectoparasiticides Introduction
11.13.4 Tagros Revenue in Ectoparasiticides Business (2019-2024)
11.13.5 Tagros Recent Development
11.14 Meghmani
11.14.1 Meghmani Company Detail
11.14.2 Meghmani Business Overview
11.14.3 Meghmani Ectoparasiticides Introduction
11.14.4 Meghmani Revenue in Ectoparasiticides Business (2019-2024)
11.14.5 Meghmani Recent Development
11.15 Crop Life Science Limited
11.15.1 Crop Life Science Limited Company Detail
11.15.2 Crop Life Science Limited Business Overview
11.15.3 Crop Life Science Limited Ectoparasiticides Introduction
11.15.4 Crop Life Science Limited Revenue in Ectoparasiticides Business (2019-2024)
11.15.5 Crop Life Science Limited Recent Development
11.16 Aestar
11.16.1 Aestar Company Detail
11.16.2 Aestar Business Overview
11.16.3 Aestar Ectoparasiticides Introduction
11.16.4 Aestar Revenue in Ectoparasiticides Business (2019-2024)
11.16.5 Aestar Recent Development
11.17 Gharda
11.17.1 Gharda Company Detail
11.17.2 Gharda Business Overview
11.17.3 Gharda Ectoparasiticides Introduction
11.17.4 Gharda Revenue in Ectoparasiticides Business (2019-2024)
11.17.5 Gharda Recent Development
11.18 Guangdong Liwei
11.18.1 Guangdong Liwei Company Detail
11.18.2 Guangdong Liwei Business Overview
11.18.3 Guangdong Liwei Ectoparasiticides Introduction
11.18.4 Guangdong Liwei Revenue in Ectoparasiticides Business (2019-2024)
11.18.5 Guangdong Liwei Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
